Chronic neutrophilic leukemia overview

Jump to navigation Jump to search

Chronic neutrophilic leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Differentiating Chronic neutrophilic leukemia from other Diseases

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT scan

MRI

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chronic neutrophilic leukemia overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chronic neutrophilic leukemia overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chronic neutrophilic leukemia overview

CDC on Chronic neutrophilic leukemia overview

Chronic neutrophilic leukemia overview in the news

Blogs on Chronic neutrophilic leukemia overview

Directions to Hospitals Treating Chronic neutrophilic leukemia

Risk calculators and risk factors for Chronic neutrophilic leukemia overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]; Grammar Reviewer: Natalie Harpenau, B.S.[3]

Overview

Chronic neutrophilic leukemia (CNL) is an extremely rare myeloproliferative neoplasms with almost 200 cases in the world. While, most of the time this disease is asymptomatic, fatigue, weight loss, night sweats, bone pain, gout and pruritus are some of its symptoms. Splenomegaly is found in examination of most patients. CSF3R mutations are seen in most patient and is responsible for pathogenesis of CNL patients. World health organization (WHO) introduces criteria for the diagnosis of chronic neutrophilic leukemia (CNL) that are based on the laboratory finding of peripheral blood cells, bone marrow, cytogenic mutation, and differential diagnosis. There is no treatment for chronic neutrophilic leukemia (CNL). Although, hematopoitic stem cell transplant, hydroxyurea, interferon, hypomethylating agents, ruxolitinib, thalidomide, cladribine, imatinib, splenic irradiation and splenectomy are some options that are used in patients with CNL. There is no treatment for chronic neutrophilic leukemia (CNL). Although, hematopoitic stem cell transplant, hydroxyurea, interferon, hypomethylating agents, ruxolitinib, thalidomide, cladribine, imatinib, splenic irradiation and splenectomy are some options that are used in patients with CNL.

Historical Perspective

Chronic neutrophilic leukemia(CNL) was first presented by Tuohy, in a case of splenomegaly and neutrophilic leukocytosis, in 1920. Although, It was named by Tanzer et al, in 1964. WHO introduced the criteria for the diagnosis of this disease as a myeloproliferative disorder in 2001. In 2013, CSF3R (colony stimulating factor 3 receptor) mutations was proposed that was found in the most CNL patients and made a huge change in diagnosis and treatment of this patient.

Classification

There is no established system for the classification of chronic neutrophilic leukemia (CNL).

Pathophysiology

The exact pathogenesis of Chronic neutrophilic leukemia (CNL) is not fully understood. Some cytogenic abnormalities like trisomy 7,8,9,21, deletion 11q, 20q6,7 may be seen in CNL patients. The mutation of CSF3R is seen in most patients. Moreover of mutation in CSF3R, there are some other genetic mutations which are less common. Polycythemia vera, plasma cell disorders and nephrotic syndrome can be associated with CNL.

Causes

The etiology of Chronic neutrophilic leukemia (CNL) is unknown.

Differentiating Chronic neutrophilic leukemia from Other Diseases

Chronic neutrophilic leukemia (CNL) must be differentiated from other diseases that cause weight loss, night sweats, hepatosplenomegaly, and palpable lymph nodes and neutrophilia.

Epidemiology and Demographics

Chronic neutrophilic leukemia is an extremely rare disease. There are almost only 200 patients with CNL worldwide. The exact incidence of CNL is undetermined.

The median age at diagnosis is 66.5 years and the incidence of disease increases with age. There is no racial predilection to CNL and it affects men and women almost equally.

Risk Factors

Chronic neutrophilic leukemia (CNL) must be differentiated from other diseases that cause weight loss, night sweats, hepatosplenomegaly, and palpable lymph nodes and neutrophilia.

Screening

There is insufficient evidence to recommend routine screening for chronic neutrophilic leukemia (CNL).

Natural History, Complications, and Prognosis

Course of the disease is variable in CNL patients, developing blast crisis is happened in most patients. Moreover, Progression to acute myeloid leukemia may seen in 10-21.2% of patients with CNL. Common complications of CNL include predisposing to hemorrhage, progression of disease, blastic or leukemic conversion and treatment-related toxicity .Prognosis is generally poor, and the 5-year survival rate of patients with CNL is approximately 28%. Some criteria same as treatment resistance, refractory neutrophilia, increasing in red blood cells, platelet transfusion dependency, deterioration of organomegaly and blast crisis indicate disease progression.


Diagnosis

Diagnostic Study of Choice

World health organization (WHO) introduces criteria for the diagnosis of chronic neutrophilic leukemia (CNL) that are based on the laboratory finding of peripheral blood cells, bone marrow, cytogenic mutation, and differential diagnosis.

History and Symptoms

The majority of patients with Chronic neutrophilic leukemia (CNL) are asymptomatic. The most common symptom is fatigue. The other symptoms of CNL include weight loss , night sweats, bone pain, easy bruising, pruritus and gout.

Physical Examination

The appearance of patient with chronic neutrphilic leukemia (CNL) is usually normal. Common physical examination findings of Chronic neutrophilic leukemia include splenomegaly, hepatomegaly, fever, petechiae, bruises, lymphadenopathy.

Laboratory Findings

A chronic elevated concentration of blood mature neutrophils is diagnostic for chronic neutrophilic leukemia (CNL). There are other blood, bone marrow and genetic tests which help the diagnosis of CNL.

Electrocardiogram

There are no ECG findings associated with chronic neutrophilic leukemia (CNL).

X-ray

There are no x-ray findings associated with chronic neutrophilic leukemia (CNL). However, an x-ray may be helpful in the diagnosis of complications of CNL, which include splenomegaly, hepatomegaly, and lymphadenopathy.

Echocardiography and Ultrasound

There are no ultrasound findings associated with chronic neutrophilic leukemia (CNL). However, an ultrasoundmay be helpful in the diagnosis of complications of CNL, which include splenomegaly, hepatomegaly, and lymphadenopathy.

CT scan

TThere are no CT scan findings associated with chronic neutrophilic leukemia (CNL). However, an CT scan may be helpful in the diagnosis of complications of CNL, which include splenomegaly, hepatomegaly, and lymphadenopathy.

MRI

There are no MRI findings associated with chronic neutrophilic leukemia (CNL). However, an MRI may be helpful in the diagnosis of complications of CNL, which include splenomegaly, hepatomegaly, and lymphadenopathy.

Other Imaging Findings

There are no other imaging findings associated with chronic neutrophilic leukemia (CNL).

Other Diagnostic Studies

Bone marrow morphology may be helpful in the diagnosis of chronic neutrophilic leukemia (CNL). Hypercellularity with myeloid hyperplasia, increasing myeloid to erythroid ratio, increasing of myelocytes, metamyelocytes, and bands, absence of basophilia and eosinophilia,Megakaryocytic hyperplasia

Treatment

Medical Therapy

There is no standard medical treatment for chronic neutrophilic leukemia (CNL). Although, Hydroxyurea, Ruxolitinib, Interferon, Thalidomide, Cladribine and Imatinib are some options that are used in patients with CNL.

Surgery

Splenectomy was used as a palliative treatment in patients of chronic neutrophilic leukemia (CNL) with splenomegaly. Although, because of neutrophilia was became worse in some reports, it's not recommended anymore.

Interventions

Hematopoitic stem cell transplant is the mainstay of treatment for CNL patients. It is recommended that every patients that are qualified for HSCT, take this treatment. Since, the therapy in blast phases has the poor outcomes, HSCT should be started as soon as possible in the disease course, before blast transformation. Splenic irradiation was used as a palliative treatment in patients of CNL with splenomegaly.

Primary Prevention

There are no established measures for the primary prevention of chronic neutrophilic leukemia (CNL).

Secondary Prevention

There are no established measures for the secondary prevention of chronic neutrophilic leukemia (CNL).

References


Template:WikiDoc Sources